# Trial of Mirtazapine for Depression in IBD

> **NCT06309472** · PHASE2 · RECRUITING · sponsor: **King's College London** · enrollment: 76 (estimated)

## Conditions studied

- Major Depressive Disorder
- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** Mirtazapine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06309472
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2026-04
- **Final completion:** 2026-10
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2024-08-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06309472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06309472, "Trial of Mirtazapine for Depression in IBD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06309472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*